Releases
ODT
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Odonate Therapeutics Inc (ODT) stock and general news. This information may help you make smarter investment decisions.
About ODT
Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).